Bafna Pharmaceuticals Limited — Major Shareholding Notification 2021

Apr 13, 2021

Date: 05th April 2021

Listing Department	Listing Department
BSE Limited	National Stock Exchange of India Limited
P J Towers	Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Mumbai - 400 001	Bandra $(E)$ , Mumbai - 400051
Security Code: 532989	Symbol: BAFNAPHARM
Security ID: BAFNAPHARM	Series : EQ

Dear Sir,

Regulation 30(2) of SEBI (Substantial Acquisition of shares and Sub.:- Disclosure under Takeovers) Regulations, 2011 for the year ended 31st March 2021

Please find attached disclosure under Regulation 30(2) of SEBI (Substantial Acquisition of shares and Takeovers) Regulations, 2011 as on 31st March 2021.

Thanking you.

Yours faithfully, For BAFNA PHARMACEUTICALS LIMITED

Mahaveer Chand Bafna Promoter and CEO (on behalf of himself, Promoter and Promoter Group/ persons acting in concert) Format for disclosures under Regulation 30(1) and 30(2) of SEBI(Substantial Acquisition of Shares and Takeovers) Regulations, 2011

Part-A-Details of shareholding

1.	Name of the Target Company	Bafna Pharmaceuticals Limited
2.	Name(s) of the stock exchange(s)	BSE Ltd1 1
	where the shares of the TC are	National Stock Exchange of India Ltd2.
	listed
3.	Particulars of the shareholder (s)
a r	Name of the person(s) together
	with Persons Acting in
	Concert(PAC) whose total
	holding(including that in the form
	of shares, warrants, convertible
	securities and any other instrument
	that would entitle the holder to
	receive shraes in the TC) is more
	than 25% of the voting rights of the
	TC.
	Or
b.	Name(s) of promoter(s), member	AS PER " ANNEXURE-A"
	of the promoter group and PAC
	with him
4.	Particulars of the shareholding of	Number of shares	% w.r.t. total	% of total
	person(s) mentioned at (3) above		share/voting	diluted
			capital wherever	share/votingcapital of TC
			applicable
	As of March 31 of the year, holding of:
	a) Shares	AS PER "ANNEXURE-A"
	Voting Rights (otherwise thanb)
	by shares)	NIL
	warrantsc)
	Convertible Securities$\mathsf{d}$
	Any other instrument thate)
	would entitle the holder to
	receive shares in the TC
	TOTAL

10 Mahaveer Chand Bafna Promoter and CEO (on behalf of himself, Promoter and Promoter Group/ persons acting in concert)

Place: Chennai Date: 05-04-2021

ANNEXURE-A

NAME OF COMPANY- BAFNA PHARMACEUTICALS LIMITED

Shareholding details of Promoter's and Promoter Group as on 31st March 2021

Sr.No	Name	No of shares	% w.r.t. totalshare/votingcapitalwhereverapplicable	% of dilutedshare / votingcapital of TC
$\mathbf{1}$	SRJR LIFESCIENCES LLP	21290701	90.00	90.00
$\mathcal{L}$	MAHAVEER CHANDBAFNA	149615	0.63	0.63
3	PARAS BAFNA	91167	0.39	0.39
4	NAVEENBAFNA M	40101	0.17	0.17
5	MAHAVEER CHANDBAFNA HUF	15823	0.07	0.07
6	PARAS BAFNA HUF	49	0.00	0.00
$\overline{7}$	SASIKALA BAFNA	62757	0.27	0.27
8	AMRI BAI BAFNA	51989	0.22	0.22
	TOTAL	21702202	91.74	91.74

Mahaveer Chand Bafna Promoter and CEO (on behalf of himself, Promoter and Promoter Group/ persons acting in concert)

Place: Chennai Date: 05-04-2021

Part-B

Name of the Target Company: BAFNA PHARMACEUTICALS LIMITED

	Cs
Promoter
Promoter
Promoter
Promoter
Promoter
Promoter
Promoter
Promoter
	Whether the person belongs toPromoter/ Promoter group

a P

Mahaveer Chand Bafna Promoter and CHO (on behalf of himself, Promoter and Promoter Group/ persons acting in concert)

Place: Chennai Date: 05-04-2021